产品展示更多>>
- INK-128 1224844-38-5

- INK-128 1224844-38-5
INK-128 1224844-38-5
产品描述 描述 INK 128 is a potent and selective mTOR inhibitor with IC50 of 1 nM; >200-fold less potent to class I PI3K isoforms.
纯度 >98%储存/保存方法 Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.基本信息 别名 沙帕色替;INK 128; INK128;Sapanisertib; MLN0128外观 白色至类白色固体可溶性/溶解性 DMSO : 58 mg/mL (187.5 mM)
Ethanol : 2 mg/mL (6.46 mM)生物活性 靶点 mTOR;mTORC1;mTORC2;PI3Kα;PI3Kγ;PI3KδIn vitro(体外研究) INK 128 exhibits an enzymatic inhibition activity against mTOR and more than 100-fold selectivity to PI3K kinases. As TORC1/2 inhibitor, INK 128 inhibits both the phosphorylation of S6 and 4EBP1, the downstream substrates of TORC1, and selectively inhibits AKT phosphorylation at Ser473, the downstream substrate of TORC2. Furthermore, INK 128 also shows potent inhibition effects on cell lines resistant to rapamycin and pan-PI3K inhibitors.In vivo(体内研究) In a ZR-75-1 breast cancer xenograft model, INK 128 shows tumor growth inhibition efficacy at a dose of 0.3 mg/kg/day. Daily, oral administration of INK 128 inhibits angiogenesis and tumor growth in multiplexenograft models.研究领域 研究领域 CancerCell cycleCell cycle inhibitorsOtherCardiovascularHeartCardiogenesisTranscription factors/regulatorsCell CycleCell Cycle InhibitorsOtherEpigeneticsDNA / RNADNA Damage & RepairDNA Damage ResponseDNA Damage RecognitionMetabolismTypes of diseaseObesityNeuroscienceDevelopmentNeuroscienceProcessesDrug DiscoverySmall Molecule DrugLead Compound DiscoveryINK-128 1224844-38-5温馨提示:本产品仅作科研实验使用,不支持临床等研究
